| 臺大學術典藏 |
2018-09-10T07:35:31Z |
Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy
|
Liu, C.-H.;Liang, C.-C.;Liu, C.-J.;Tsai, H.-B.;Hung, P.-H.;Hsu, S.-J.;Chen, S.-L.;Lin, J.-W.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-05-24T07:20:53Z |
Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy
|
CHEN-HUA LIU; Liang C.-C.; Liu C.-J.; Tsai H.-B.; Hung P.-H.; Hsu S.-J.; Chen S.-L.; Lin J.-W.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:54Z |
Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tsai H.-B.; Hung P.-H.; Hsu S.-J.; Chen S.-L.; Lin J.-W.; Lai M.-Y.; Chen J.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T06:12:27Z |
Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tsai H.-B.; Hung P.-H.; Hsu S.-J.; Chen S.-L.; Lin J.-W.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-01-24T09:32:03Z |
Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy
|
Liu C.-H.; Liang C.-C.; CHUN-JEN LIU; Tsai H.-B.; Hung P.-H.; Hsu S.-J.; Chen S.-L.; Lin J.-W.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 中國醫藥大學 |
2009-03-14 |
PEGYLATED INTERFERON α-2A THERAPY FOR HBEAG-NEGATIVE CHRONIC HEPATITIS B
|
賴學洲(Hsueh-Chou Lai); 彭成元(Cheng-Yuan Peng); 蘇文邦(Wen-Pang Su); 莊伯恒(Po-Heng Chuang); 高榮達(Jung-Ta Kao); 周仁偉(Jen-Wei Chou); 賴學洲(Hsueh-Chou Lai) |
| 臺大學術典藏 |
2021-07-03T03:35:05Z |
Pegylated interferon α-2a versus standard interferon α-2a for treatment-na?ve dialysis patients with chronic hepatitis C: A randomised study
|
Liu C.-H.; Liang C.-C.; Lin J.-W.; Chen S.-I.; Tsai H.-B.; Chang C.-S.; Hung P.-H.; Kao J.-H.; Liu C.-J.; Lai M.-Y.; Chen J.-H.; PEI-JER CHEN; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2022-01-24T09:32:09Z |
Pegylated interferon α-2a versus standard interferon α-2a for treatment-na?ve dialysis patients with chronic hepatitis C: A randomised study
|
Liu C.-H.; Liang C.-C.; Lin J.-W.; Chen S.-I.; Tsai H.-B.; Chang C.-S.; Hung P.-H.; Kao J.-H.; CHUN-JEN LIU; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:12:36Z |
Pegylated interferon α-2a versus standard interferon α-2a for treatment-na?ve dialysis patients with chronic hepatitis C: A randomised study
|
Liu C.-H.; Liang C.-C.; Lin J.-W.; Chen S.-I.; Tsai H.-B.; Chang C.-S.; Hung P.-H.; JIA-HORNG KAO; Liu C.-J.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2018-09-10T07:02:32Z |
Pegylated interferon α-2a versus standard interferon α-2a for treatment-naïve dialysis patients with chronic hepatitis C: A randomised study
|
Liu, C.-H.;Liang, C.-C.;Lin, J.-W.;Chen, S.-I.;Tsai, H.-B.;Chang, C.-S.;Hung, P.-H.;Kao, J.-H.;Liu, C.-J.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-05-24T07:20:55Z |
Pegylated interferon α-2a versus standard interferon α-2a for treatment-naïve dialysis patients with chronic hepatitis C: A randomised study
|
CHEN-HUA LIU; Liang C.-C.; Lin J.-W.; Chen S.-I.; Tsai H.-B.; Chang C.-S.; Hung P.-H.; Kao J.-H.; Liu C.-J.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Kao J.-H.; Chen D.-S. |
| 國立臺灣大學 |
2013 |
Pegylated Interferon-alpha 2a With or Without Low-Dose Ribavirin for Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Receiving Hemodialysis A Randomized Trial
|
Liu, Chen-Hua; Huang, Chung-Feng; Liu, Chun-Jen; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Chen, Shih-I; Lin, Jou-Wei; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳世宜; 陳培哲; 蔡孟昆; 林昭維; 蔡宏斌 |
| 國立臺灣大學 |
2008 |
Pegylated Interferon-Alpha-2a Plus Ribavirin for Treatment-Naive Asian Patients with Hepatitis C Virus Genotype 1 Infection: A Multicenter, Randomized Controlled Trial
|
劉振驊; 劉俊人; 林志陵; 梁程超; 徐士哲; 楊勝舜; 許景盛; 曾岱宗; 王嘉齊; 賴明陽; 陳俊恒; 陳培哲; 陳定信; 高嘉宏; LIU, CHEN-HUA; LIU, CHUN-JEN; LIN, CHIH-LIN; LIANG, CHENG-CHAO; HSU, SHIH-JER; YANG, SHENG-SHUN; HSU, CHING-SHENG; TSENG, TAI-CHUNG; WANG, CHIA-CHI; LAI, MING-YANG; CHEN, JUN-HENG; CHEN, PEI-JER; CHEN, DING-SHINN; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T07:02:32Z |
Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trial
|
Liu, C.-H.;Liu, C.-J.;Lin, C.-.;Liang, C.-C.;Hsu, S.-J.;Yang, S.-S.;Hsu, C.-S.;Tseng, T.-C.;Wang, C.-C.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-05-24T07:20:53Z |
Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trial
|
CHEN-HUA LIU; Liu C.-J.; Lin C.-.; Liang C.-C.; Hsu S.-J.; Yang S.-S.; Hsu C.-S.; Tseng T.-C.; Wang C.-C.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:58Z |
Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trial
|
Liu C.-H.; Liu C.-J.; Lin C.-.; Liang C.-C.; Hsu S.-J.; Yang S.-S.; Hsu C.-S.; Tseng T.-C.; Wang C.-C.; Lai M.-Y.; Chen J.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T06:12:31Z |
Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trial
|
Liu C.-H.; Liu C.-J.; Lin C.-.; Liang C.-C.; Hsu S.-J.; Yang S.-S.; Hsu C.-S.; Tseng T.-C.; Wang C.-C.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-01-24T09:32:06Z |
Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trial
|
Liu C.-H.; CHUN-JEN LIU; Lin C.-.; Liang C.-C.; Hsu S.-J.; Yang S.-S.; Hsu C.-S.; Tseng T.-C.; Wang C.-C.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2018-09-10T09:52:02Z |
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: A randomized trial
|
Liu, C.-H. and Huang, C.-F. and Liu, C.-J. and Dai, C.-Y. and Liang, C.-C. and Huang, J.-F. and Hung, P.-H. and Tsai, H.-B. and Tsai, M.-K. and Chen, S.-I. and Lin, J.-W. and Yang, S.-S. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Chuang, W.-L. and Yu, M.-L. and Kao, J.-H.; CHEN-HUA LIU |
| 臺大學術典藏 |
2019-12-04T02:00:04Z |
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: A randomized trial
|
Liu C.-H.;Huang C.-F.;Liu C.-J.;Dai C.-Y.;Liang C.-C.;Huang J.-F.;Hung P.-H.;Tsai H.-B.;Meng-Kun Tsai;Chen S.-I.;Lin J.-W.;Yang S.-S.;Su T.-H.;Yang H.-C.;Chen P.-J.;Chen D.-S.;Chuang W.-L.;Yu M.-L.;Kao J.-H.; Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; MENG-KUN TSAI; Chen S.-I.; Lin J.-W.; Yang S.-S.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:41Z |
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: A randomized trial
|
Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Chen S.-I.; Lin J.-W.; Yang S.-S.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:40Z |
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: A randomized trial
|
CHEN-HUA LIU; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Chen S.-I.; Lin J.-W.; Yang S.-S.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:14Z |
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: A randomized trial
|
Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Chen S.-I.; Lin J.-W.; Yang S.-S.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T06:11:44Z |
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: A randomized trial
|
Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Chen S.-I.; Lin J.-W.; Yang S.-S.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-01-24T09:31:44Z |
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: A randomized trial
|
Liu C.-H.; Huang C.-F.; CHUN-JEN LIU; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Chen S.-I.; Lin J.-W.; Yang S.-S.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H. |
| 臺大學術典藏 |
2018-09-10T09:39:54Z |
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.
|
Dai, Chia-Yen; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Hung-Bin; Tsai, Meng-Kun; Chen, Shih-I; Lin, Jou-Wei; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Liang, Cheng-Chao;Huang, Jee-Fu;Hung, Peir-Haur;Tsai, Hung-Bin;Tsai, Meng-Kun;Chen, Shih-I;Lin, Jou-Wei;Yang, Sheng-Shun;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Yu, Ming-Lung;Kao, Jia-Horng; Liu, Chun-Jen; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳世宜;陳培哲;蔡孟昆;林昭維;蔡宏斌; Liu, Chen-Hua; Liu, Chen-Hua; CHEN-HUA LIU; Huang, Chung-Feng; Huang, Chung-Feng; Liu, Chun-Jen |
| 臺大學術典藏 |
2021-07-12T02:44:47Z |
Pegylated interferon-�\2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: A randomized trial
|
Liu C.-H; | Huang C.-F; | Liu C.-J; | Dai C.-Y; | Liang C.-C; | Huang J.-F; | Hung P.-H; | Tsai H.-B; | Tsai M.-K; | Chen S.-I; | Lin J.-W; | Yang S.-S; | Su T.-H; | HUNG-CHIH YANG; | Chen P.-J; | Chen D.-S; | Chuang W.-L; | Yu M.-L; | Kao J.-H. |
| 臺大學術典藏 |
2018-09-10T06:00:49Z |
Pegylated interferons for the treatment of chronic hepatitis B.
|
Liu, C.J.;Kao, J.H.; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:19:00Z |
Pegylated interferons for the treatment of chronic hepatitis B.
|
Liu C.J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-01-24T09:32:19Z |
Pegylated interferons for the treatment of chronic hepatitis B.
|
CHUN-JEN LIU; Kao J.H. |
| 國立臺灣大學 |
2006-06 |
Pegylated liposomal doxorubicin (Lipo-Dox(R)) for platinum-resistant or refractory epithelial ovarian carcinoma: A Taiwanese gynecologic oncology group study with long-term follow-up.
|
Chou, HH; Wang, KL; Chen, CA; Wei, LH; Lai, CH; Hsieh, CY; Yang, YC; Twu, NF; Chang, TC; Yen, MS. |
| 臺大學術典藏 |
2020-01-22T07:50:48Z |
Pegylated liposomal doxorubicin (Lipo-Dox?) for platinum-resistant or refractory epithelial ovarian carcinoma: A Taiwanese gynecologic oncology group study with long-term follow-up
|
Chou H.-H.;Wang K.-L.;Chi-An Chen;Wei L.-H.;Lai C.-H.;Hsieh C.-Y.;Yang Y.-C.;Twu N.-F.;Chang T.-C.;Yen M.-S.; Chou H.-H.; Wang K.-L.; CHI-AN CHEN; Wei L.-H.; Lai C.-H.; Hsieh C.-Y.; Yang Y.-C.; Twu N.-F.; Chang T.-C.; Yen M.-S. |
| 臺大學術典藏 |
2006 |
Pegylated liposomal doxorubicin (Lipo-Dox?) for platinum-resistant or refractory epithelial ovarian carcinoma: A Taiwanese gynecologic oncology group study with long-term follow-up
|
Chang T.-C; Yen M.-S.; Twu N.-F; Yang Y.-C; Hsieh C.-Y; Lai C.-H; LING-HUNG WEI; Chen C.-A; Wang K.-L; Chou H.-H; Yen M.-S.;Chang T.-C;Twu N.-F;Yang Y.-C;Hsieh C.-Y;Lai C.-H;LING-HUNG WEI;Chen C.-A;Wang K.-L;Chou H.-H |
| 臺大學術典藏 |
2020-11-27T08:14:29Z |
Pegylated liposomal doxorubicin (Lipo-Dox?) for platinum-resistant or refractory epithelial ovarian carcinoma: A Taiwanese gynecologic oncology group study with long-term follow-up
|
Chou H.-H.;Wang K.-L.;Chen C.-A.;Wei L.-H.;Lai C.-H.;Chang-Yao Hsieh;Yang Y.-C.;Twu N.-F.;Chang T.-C.;Yen M.-S.; Chou H.-H.; Wang K.-L.; Chen C.-A.; Wei L.-H.; Lai C.-H.; CHANG-YAO HSIEH; Yang Y.-C.; Twu N.-F.; Chang T.-C.; Yen M.-S. |
| 臺大學術典藏 |
2018-09-10T06:07:07Z |
Pegylated liposomal doxorubicin (Lipo-Dox®) for platinum-resistant or refractory epithelial ovarian carcinoma: A Taiwanese gynecologic oncology group study with long-term follow-up
|
Chou, H.-H. and Wang, K.-L. and Chen, C.-A. and Wei, L.-H. and Lai, C.-H. and Hsieh, C.-Y. and Yang, Y.-C. and Twu, N.-F. and Chang, T.-C. and Yen, M.-S.; CHI-AN CHEN |
| 國立臺灣大學 |
2016 |
Pegylated Liposomal Doxorubicin as Adjuvant Therapy for Stage I-III Operable Breast Cancer
|
Lu, Yin-Che; Ou-Yang, Fu; Hsieh, Chia-Ming; Chang, King-Jen; Chen, Dar-Ren; Tu, Chi-Wen; Wang, Hwei-Chung; Hou, Ming-Feng; 張金堅 |
| 嘉南藥理大學 |
2016-03 |
Pegylated Liposomal Doxorubicin as Adjuvant Therapy for Stage I-III Operable Breast Cancer
|
Lu, Yin-Che; Ou-Yang, Fu; Hsieh, Chia-Ming; Chang, King-Jen; Chen, Dar-Ren; Tu, Chi-Wen; Wang, Hwei-Chung; Hou, Ming-Feng |
| 臺大學術典藏 |
2022-08-12T06:27:30Z |
Pegylated Liposomal Doxorubicin as Adjuvant Therapy for Stage I-III Operable Breast Cancer
|
Lu Y.-C.; Ou-Yang F.U.; Hsieh C.-M.; KING-JEN CHANG; Chen D.-R.; Tu C.-W.; Wang H.-C.; Hou M.-F. |
| 國立臺灣大學 |
2000 |
Pegylated Liposomal Doxorubicin in Treating a Case of Advanced Hepatocellular Carcinoma with Severe Hepatic Dysfunction and Pharmacokinetic Study
|
洪瑞隆; HONG, RUEY-LONG |
| 臺大學術典藏 |
2020-01-21T06:06:02Z |
Pegylated liposomal doxorubicin in treating a case of advanced hepatocellular carcinoma with severe hepatic dysfunction and pharmacokinetic study
|
Hong R.-L.;Tseng Y.-L.;Fu-Hsiung Chang; Hong R.-L.; Tseng Y.-L.; FU-HSIUNG CHANG |
| 臺大學術典藏 |
2021-03-09T06:46:17Z |
Pegylated liposomal doxorubicin in treating a case of advanced hepatocellular carcinoma with severe hepatic dysfunction and pharmacokinetic study
|
Ruey-Long Hong;Tseng Y.-L.;Chang F.-H.; RUEY-LONG HONG; Tseng Y.-L.; Chang F.-H. |
| 國立臺灣大學 |
2000-10 |
Pegylated liposomal doxorubicin in treating a case of advanced hepatocellular carcinoma with severe hepatic dysfunction and pharmacokinetic study.
|
Hong, R.-L.; Tseng, Y.-L.; Chang, F.-H. |
| 嘉南藥理大學 |
2011-04 |
PEGylated Liposomes Incorporated with Nonionic Surfactants as an Apomorphine Delivery System Targeting the Brain: In Vitro Release and In Vivo Real-time Imaging
|
Hsu, Shu-Hui; Saleh, A.Al-Suwayeh; Chen, Chih-Chieh; Chi, Chen-Hsien; Fang, Jia-You |
| 元智大學 |
Jun-15 |
PEGylated Poly(3-hydroxybutyrate) Scaffold for Hydration-Driven Cell Infiltration, Neo-Tissue Ingrowth, and Osteogenic Potential
|
Mei-Chan Sin; Sun Y.-M.; Chao-Ling Yao; Chung-Jung Chou; Hsueh-Wei Tseng; Jei Zheng |
| 臺北醫學大學 |
2010-02 |
Pegylated Polyester Polymeric Micelles as a Nano-carrier: Synthesis, Characterization, Degradation, and Biodistribution
|
Wen-Jen Lin; Lee-Wei Juang; Chia-Ling Wang; Yi-Chen Chen; Chi-Chang Lin; Kai-Ling Chang |
| 臺大學術典藏 |
2010 |
Pegylated Polyester Polymeric Micelles as a Nano-carrier: Synthesis, Characterization, Degradation, and Biodistribution
|
Wen-Jen Lin;Juang L.-W.;Wang C.-L.;Chen Y.-C.;Lin C.-C.;Chang K.-L.; Chang K.-L.; Lin C.-C.; Chen Y.-C.; Wang C.-L.; Juang L.-W.; WEN-JEN LIN |
| 國立臺灣大學 |
2011 |
PEGylated silica nanoparticles encapsulating multiple magnetite nanocrystals for high-performance microscopic magnetic resonance angiography
|
Wu, Si-Han; Lin, Chien-Yuan; Hung, Yann; Chen, Wei; Chang, Chen; Mou, Chung-Yuan |
| 臺大學術典藏 |
2018-09-10T08:36:23Z |
PEGylated silica nanoparticles encapsulating multiple magnetite nanocrystals for high-performance microscopic magnetic resonance angiography
|
Mou, C.-Y.; CHUNG-YUAN MOU; Chang, C.; Hung, Y.; Chen, W.; Lin, C.-Y.; Wu, S.-H.; Wu, S.-H.;Lin, C.-Y.;Hung, Y.;Chen, W.;Chang, C.;Mou, C.-Y. |
| 中國醫藥大學 |
2015-04 |
Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients
|
葉明倫(Ming-Lun Yeh);彭成元(Cheng-Yuan Peng);戴嘉言(Chia-Yen Dai);賴學洲(Hsueh-Chou Lai);黃釧峰(Chung-Feng Huang);謝明彥(Ming-Yen Hsieh);黃志富(Jee-Fu Huang);陳信成(Shinn-Cherng Chen);林子堯(Zu-Yau Lin);余明隆(Ming-Lung Yu)*;莊萬龍(Wan-Long Chuang)* |
| 國立臺灣大學 |
2015 |
Pegylation effect of chitosan based polyplex on DNA transfection
|
Lin, Wen Jen; Hsu, Wan Yi; 林文貞 |
